9月22日，国家食品药品监督管理总局在中国政府法制信息网上公布了《食品药品行政处罚程序规定﹙征求意见稿﹚》，向社会公开征求意见，意见反馈截止时间为2013年10月22日。征求意见稿对食品药品监督管理部门办理行政处罚案件的地域管辖作出规定，国家食品药品监督管理总局依职权管辖全国范围内有重大影响的食品药品行政处罚案件。省、自治区、直辖市人民政府食品药品监督管理部门管辖本辖区内重大、复杂的食品药品行政处罚案件。县级以上食品药品监督管理部门管辖本辖区内的食品药品行政处罚案件。征求意见稿指出，食品药品监督管理部门对在监督检查中发现的，检验机构检验发现，公民、法人及其他组织投诉、申诉和举报的以及上级交办的、下级报请查处的、有关部门移送的或者其他方式、途径披露的涉案举报线索及交办、报送的案件应当及时处理。其中，发现有明确的违法嫌疑人、有客观的违法事实、属于食品药品监督管理行政处罚的范围内及属于本部门管辖的违法行为的，应当在7个工作日内立案。

2013年1-8月，医药行业总体呈现平稳发展态势。从主要运行指标来看，投资保持较快增长，利用外资形势向好；增加值增长率进一步回升；中西药品零售额增速进一步放缓；进出口增速不及上年同期水平，但出口增速与上年同期相比略有恢复；生产者出厂价格保持回升势头放缓，医疗保健和个人用品价格涨幅收窄，中西药品及医疗保健用品零售价格降中企稳；利润增速依旧低于收入增速，但利润和主营活动利润增速环比均有所提高。未来一段时期，医药经济总体将保持平稳增长，产销增幅或将有所回升，药价水平总体趋降，出口或将出现复苏势头，而成本高的企业，其利润增幅提升仍然存在变数。

报告从行业事件分析、竞争环境、医药研发、竞争对手、行业数据等几个方面进行了分析评论。

报告从政策环境、市场行情、厂商动态、科技研发、国际资讯、行业数据、分析评论等几个方面进行了分析评论。

Psoriasis is a chronic inflammatory disease of the skin. It is a skin disorder characterized by epidermal hyper proliferation and dermal inflammation that differ in severity, from small, confined patches to complete body coverage. It affects approximately 2–3 percent of the population, making it one of the most prevalent autoimmune diseases worldwide. In this disease skin cells replicate at an exceptionally rapid rate, about eight times faster than the normal skin cells. This results in the build-up of cells on the skin's surface forming thick patches or plaques. It is a lifelong skin disease that begins in the immune system, mainly with a type of white blood cell called a T-cell. T-cells help protect the body against infection and disease. In psoriasis, T-cells are set into action by error and they turn out to be so active that they start out other immune responses. This results into swelling and quick turnover of skin cells. There is no cure for psoriasis. But numerous topical, systemic, and biologic therapies are available for the treatment of mild psoriasis or controlling the severe psoriasis. Treatment modalities are chosen on the basis of disease severity, cost, efficacy, patient preference, and evaluation of individual patient response.

Stem cells are undifferentiated cells with self-renewal and differentiation properties. Stem cell products are applied in numerous permutations of methods with the usage of cells, engineering and materials, and appropriate biochemical factors. At present, stem cell-based therapies used in cancer treatment are chiefly of the hematopoietic variety, although at the research level, there is a noteworthy increase in embryonic, pluripotent, and other stem cell therapies. Currently there are no FDA-approved stem cell therapies; however there are a few FDA-approved stem cell therapies that are used adjunctively as part of an oncology therapy. These therapies have either a tissue regenerative effect, a tissue protective effect, or an anti–cancer effect. Stem cells have been used to renew the blood and immune systems impaired by cancer cells or during the treatment of cancer, i.e., by chemotherapy or radiotherapy. Apart from their use in the immunomodulation, stem cells have been proven to contribute to tissue regeneration and as delivery vehicles in the cancer treatment. The recent theory of cancer stem cells has engaged scientific communities towards a different wide new area of research field with possible potential future treatment modalities for cancer. Stem cell therapy is an emerging field and leading pharmaceutical companies are showing considerable interest in this area. Stem cells offer immense potential for treating various untreatable diseases.

IT in the Healthcare sector is extremely useful to improve the quality and efficiency of services delivered. Though increased investments on IT systems will eventually lead to higher expenditure by patients due to the advanced technology used, healthcare providers still choose to increase their spending on IT. Both the Private and Public sectors are engaging in various projects that have increased the usage of IT in healthcare. Private companies are especially seen to be spending more on IT and this trend is forecast to continue in the coming years. Maintenance of standard record formats and financial incentives from governments and other international welfare organizations will further encourage investments in IT systems in the Healthcare sector. IT will help enhancing the delivery systems in the Healthcare sector and reduce the occurrence of errors.